ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg),
Recall reason: Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.. Recalled by ACCORD HEALTHCARE, INC.. Distribution: Nationwide in the US. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot # D2300045, Exp 12/31/2025.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report